 Karen Wilson
Concepts (293)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tobacco Smoke Pollution | 23 | 2021 | 227 | 11.010 |
Why?
| | Cotinine | 9 | 2020 | 64 | 4.180 |
Why?
| | Smoking Cessation | 8 | 2021 | 376 | 2.650 |
Why?
| | Hospitalization | 19 | 2020 | 1645 | 2.030 |
Why?
| | Environmental Exposure | 5 | 2020 | 423 | 1.940 |
Why?
| | Bronchiolitis | 5 | 2020 | 74 | 1.840 |
Why?
| | Housing | 4 | 2021 | 108 | 1.790 |
Why?
| | Marijuana Smoking | 3 | 2020 | 224 | 1.760 |
Why?
| | Smoke-Free Policy | 3 | 2021 | 14 | 1.740 |
Why?
| | Hospitals, Pediatric | 15 | 2021 | 489 | 1.670 |
Why?
| | Pediatrics | 8 | 2021 | 1051 | 1.640 |
Why?
| | Smoke | 4 | 2020 | 134 | 1.620 |
Why?
| | Electronic Nicotine Delivery Systems | 6 | 2021 | 45 | 1.590 |
Why?
| | Hospital Medicine | 4 | 2017 | 55 | 1.570 |
Why?
| | Parents | 8 | 2020 | 1096 | 1.540 |
Why?
| | Tobacco Smoking | 3 | 2021 | 18 | 1.500 |
Why?
| | Hospitalists | 5 | 2021 | 146 | 1.450 |
Why?
| | Cannabis | 4 | 2021 | 277 | 1.350 |
Why?
| | Child | 47 | 2022 | 17357 | 1.300 |
Why?
| | Tobacco Products | 4 | 2021 | 55 | 1.270 |
Why?
| | Child, Preschool | 35 | 2021 | 9655 | 1.200 |
Why?
| | Biomarkers | 5 | 2020 | 3464 | 1.190 |
Why?
| | Dronabinol | 3 | 2020 | 100 | 1.110 |
Why?
| | Asthma | 8 | 2019 | 1902 | 1.100 |
Why?
| | Infant | 25 | 2022 | 8024 | 1.050 |
Why?
| | Influenza, Human | 4 | 2017 | 460 | 1.000 |
Why?
| | Croup | 2 | 2022 | 13 | 1.000 |
Why?
| | Vaping | 2 | 2019 | 24 | 0.960 |
Why?
| | Child, Hospitalized | 2 | 2020 | 44 | 0.950 |
Why?
| | Smoking | 9 | 2021 | 1627 | 0.920 |
Why?
| | Length of Stay | 9 | 2022 | 1057 | 0.920 |
Why?
| | Adolescent | 40 | 2021 | 18577 | 0.900 |
Why?
| | Humans | 77 | 2022 | 112249 | 0.840 |
Why?
| | Seizures | 3 | 2018 | 330 | 0.840 |
Why?
| | Tobacco | 5 | 2021 | 147 | 0.810 |
Why?
| | Cesarean Section | 1 | 2020 | 147 | 0.790 |
Why?
| | Conversion Disorder | 1 | 2018 | 8 | 0.740 |
Why?
| | Male | 53 | 2021 | 60715 | 0.740 |
Why?
| | Female | 54 | 2021 | 62624 | 0.730 |
Why?
| | Patient Admission | 3 | 2018 | 200 | 0.720 |
Why?
| | Air Pollution, Indoor | 1 | 2018 | 113 | 0.690 |
Why?
| | Cytokines | 2 | 2018 | 1974 | 0.680 |
Why?
| | Medical Marijuana | 1 | 2018 | 119 | 0.640 |
Why?
| | Child Health | 1 | 2018 | 92 | 0.640 |
Why?
| | Medical Audit | 1 | 2016 | 84 | 0.640 |
Why?
| | United States | 23 | 2021 | 12170 | 0.630 |
Why?
| | Systemic Inflammatory Response Syndrome | 3 | 2021 | 74 | 0.620 |
Why?
| | Personal Satisfaction | 1 | 2017 | 173 | 0.610 |
Why?
| | Retrospective Studies | 23 | 2020 | 11118 | 0.610 |
Why?
| | Dexamethasone | 5 | 2022 | 318 | 0.600 |
Why?
| | Encephalitis | 1 | 2017 | 119 | 0.600 |
Why?
| | Counseling | 3 | 2021 | 360 | 0.600 |
Why?
| | Influenza Vaccines | 2 | 2017 | 407 | 0.600 |
Why?
| | Biomedical Research | 3 | 2017 | 605 | 0.580 |
Why?
| | Information Dissemination | 1 | 2017 | 201 | 0.560 |
Why?
| | Epilepsy | 1 | 2018 | 267 | 0.550 |
Why?
| | Pneumonia | 3 | 2019 | 557 | 0.550 |
Why?
| | Social Media | 1 | 2017 | 139 | 0.540 |
Why?
| | Leukocytosis | 1 | 2013 | 38 | 0.530 |
Why?
| | Nonprescription Drugs | 3 | 2011 | 71 | 0.520 |
Why?
| | Complementary Therapies | 2 | 2006 | 79 | 0.520 |
Why?
| | Health Policy | 1 | 2017 | 352 | 0.520 |
Why?
| | Colorado | 7 | 2020 | 4552 | 0.510 |
Why?
| | Adolescent Health Services | 3 | 2002 | 65 | 0.510 |
Why?
| | Medication Errors | 2 | 2011 | 97 | 0.500 |
Why?
| | Infant, Newborn | 11 | 2021 | 5017 | 0.490 |
Why?
| | Abdominal Pain | 1 | 2013 | 128 | 0.480 |
Why?
| | Peer Review, Research | 1 | 2012 | 41 | 0.480 |
Why?
| | Vaccination | 2 | 2017 | 932 | 0.480 |
Why?
| | Internet | 1 | 2017 | 627 | 0.470 |
Why?
| | Patient Readmission | 6 | 2018 | 617 | 0.470 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2011 | 66 | 0.470 |
Why?
| | Hypertension | 1 | 2020 | 1166 | 0.450 |
Why?
| | New York City | 2 | 2021 | 77 | 0.430 |
Why?
| | Health Services Research | 1 | 2013 | 395 | 0.430 |
Why?
| | Micronutrients | 1 | 2011 | 74 | 0.420 |
Why?
| | Carotid Arteries | 1 | 2011 | 194 | 0.420 |
Why?
| | Child Welfare | 1 | 2011 | 219 | 0.400 |
Why?
| | Tonsillectomy | 3 | 2015 | 67 | 0.390 |
Why?
| | Cross-Sectional Studies | 9 | 2021 | 4207 | 0.390 |
Why?
| | Young Adult | 11 | 2021 | 10899 | 0.390 |
Why?
| | Cohort Studies | 10 | 2019 | 4937 | 0.380 |
Why?
| | Inpatients | 4 | 2022 | 329 | 0.370 |
Why?
| | Inflammation Mediators | 1 | 2012 | 555 | 0.370 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2010 | 211 | 0.360 |
Why?
| | Surveys and Questionnaires | 7 | 2021 | 4549 | 0.360 |
Why?
| | Patient Discharge | 3 | 2018 | 709 | 0.350 |
Why?
| | Antioxidants | 1 | 2011 | 569 | 0.340 |
Why?
| | Adolescent Behavior | 3 | 2006 | 514 | 0.330 |
Why?
| | Smoking Prevention | 2 | 2020 | 164 | 0.320 |
Why?
| | Sex Factors | 3 | 2020 | 1995 | 0.320 |
Why?
| | Health Knowledge, Attitudes, Practice | 3 | 2011 | 1225 | 0.320 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2011 | 458 | 0.310 |
Why?
| | Quality Improvement | 1 | 2013 | 915 | 0.310 |
Why?
| | Adult | 13 | 2021 | 31789 | 0.300 |
Why?
| | Dietary Supplements | 2 | 2006 | 430 | 0.300 |
Why?
| | Electroencephalography | 2 | 2018 | 494 | 0.290 |
Why?
| | Perioperative Care | 2 | 2015 | 133 | 0.260 |
Why?
| | Socioeconomic Factors | 2 | 2018 | 1206 | 0.260 |
Why?
| | Severity of Illness Index | 4 | 2016 | 2817 | 0.250 |
Why?
| | Marketing | 2 | 2019 | 26 | 0.250 |
Why?
| | Diabetic Ketoacidosis | 2 | 2016 | 163 | 0.240 |
Why?
| | Coitus | 1 | 2002 | 31 | 0.240 |
Why?
| | Risk Factors | 5 | 2020 | 8978 | 0.240 |
Why?
| | Pandemics | 4 | 2021 | 807 | 0.230 |
Why?
| | Public Housing | 1 | 2021 | 5 | 0.230 |
Why?
| | Contraception | 1 | 2002 | 106 | 0.220 |
Why?
| | Tobacco Use | 1 | 2020 | 33 | 0.210 |
Why?
| | Guideline Adherence | 2 | 2015 | 527 | 0.210 |
Why?
| | Hospital Costs | 3 | 2016 | 124 | 0.210 |
Why?
| | Glucocorticoids | 2 | 2015 | 538 | 0.200 |
Why?
| | Prevalence | 2 | 2017 | 2383 | 0.200 |
Why?
| | Nutrition Surveys | 1 | 2020 | 207 | 0.190 |
Why?
| | Behavior Control | 1 | 2018 | 15 | 0.190 |
Why?
| | Workload | 1 | 2019 | 135 | 0.180 |
Why?
| | Quality of Health Care | 2 | 2014 | 644 | 0.180 |
Why?
| | Substance Abuse Detection | 1 | 2018 | 61 | 0.180 |
Why?
| | Attitude to Health | 2 | 2017 | 408 | 0.180 |
Why?
| | Leadership | 1 | 2021 | 296 | 0.180 |
Why?
| | Odds Ratio | 2 | 2018 | 1061 | 0.180 |
Why?
| | Respiratory Tract Diseases | 1 | 2019 | 156 | 0.180 |
Why?
| | Journal Impact Factor | 1 | 2017 | 28 | 0.180 |
Why?
| | Weight Loss | 2 | 2018 | 692 | 0.180 |
Why?
| | Coronavirus Infections | 2 | 2020 | 338 | 0.180 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 353 | 0.170 |
Why?
| | Pregnancy | 3 | 2020 | 5185 | 0.170 |
Why?
| | Limit of Detection | 1 | 2016 | 56 | 0.170 |
Why?
| | Tertiary Healthcare | 1 | 2016 | 23 | 0.170 |
Why?
| | Urinalysis | 1 | 2016 | 61 | 0.160 |
Why?
| | Prospective Studies | 4 | 2022 | 6167 | 0.160 |
Why?
| | Technology | 1 | 2017 | 59 | 0.160 |
Why?
| | Migraine Disorders | 1 | 2017 | 70 | 0.160 |
Why?
| | Universities | 1 | 2019 | 350 | 0.160 |
Why?
| | Infant, Low Birth Weight | 1 | 2017 | 133 | 0.160 |
Why?
| | Health Personnel | 2 | 2017 | 477 | 0.160 |
Why?
| | Herbal Medicine | 2 | 2006 | 5 | 0.160 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2021 | 660 | 0.160 |
Why?
| | Respiratory Tract Infections | 1 | 2019 | 258 | 0.160 |
Why?
| | Video Recording | 1 | 2017 | 134 | 0.160 |
Why?
| | Oseltamivir | 1 | 2016 | 12 | 0.160 |
Why?
| | Health Behavior | 1 | 2002 | 716 | 0.160 |
Why?
| | Transcriptome | 1 | 2021 | 680 | 0.150 |
Why?
| | Monitoring, Physiologic | 1 | 2018 | 276 | 0.150 |
Why?
| | Publishing | 1 | 2017 | 158 | 0.150 |
Why?
| | Immunization Schedule | 1 | 2016 | 143 | 0.150 |
Why?
| | Subacute Care | 1 | 2016 | 62 | 0.150 |
Why?
| | Tobacco Industry | 1 | 2015 | 46 | 0.150 |
Why?
| | Delivery of Health Care | 1 | 2002 | 684 | 0.150 |
Why?
| | Cancer Survivors | 1 | 2018 | 150 | 0.150 |
Why?
| | China | 1 | 2015 | 244 | 0.150 |
Why?
| | Tobacco, Smokeless | 1 | 2014 | 18 | 0.150 |
Why?
| | Magnesium | 1 | 2015 | 153 | 0.140 |
Why?
| | Prednisone | 1 | 2015 | 245 | 0.140 |
Why?
| | Administration, Intravenous | 1 | 2015 | 142 | 0.140 |
Why?
| | Public Health | 1 | 2019 | 419 | 0.140 |
Why?
| | Steroids | 1 | 2015 | 135 | 0.140 |
Why?
| | Patient Handoff | 1 | 2014 | 31 | 0.140 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2016 | 134 | 0.140 |
Why?
| | Community-Acquired Infections | 1 | 2015 | 129 | 0.140 |
Why?
| | Role | 1 | 2013 | 33 | 0.140 |
Why?
| | Nicotinic Agonists | 1 | 2015 | 126 | 0.140 |
Why?
| | Tachypnea | 1 | 2013 | 3 | 0.130 |
Why?
| | Hospitals, Community | 1 | 2013 | 41 | 0.130 |
Why?
| | Patient Care | 1 | 2014 | 100 | 0.130 |
Why?
| | Wit and Humor as Topic | 1 | 2013 | 7 | 0.130 |
Why?
| | Benchmarking | 1 | 2014 | 137 | 0.130 |
Why?
| | Medical Errors | 1 | 2014 | 101 | 0.130 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1430 | 0.130 |
Why?
| | Postoperative Hemorrhage | 1 | 2014 | 71 | 0.130 |
Why?
| | Depressive Disorder | 1 | 2017 | 384 | 0.130 |
Why?
| | Continuity of Patient Care | 1 | 2016 | 272 | 0.130 |
Why?
| | Periodicals as Topic | 1 | 2017 | 262 | 0.130 |
Why?
| | Home Care Services | 1 | 2016 | 227 | 0.130 |
Why?
| | Tachycardia | 1 | 2013 | 59 | 0.130 |
Why?
| | Nicotine | 1 | 2015 | 264 | 0.130 |
Why?
| | Research | 1 | 2017 | 461 | 0.130 |
Why?
| | Interleukin-5 | 1 | 2012 | 30 | 0.120 |
Why?
| | Teaching Rounds | 1 | 2013 | 47 | 0.120 |
Why?
| | Probability | 1 | 2013 | 339 | 0.120 |
Why?
| | Regression Analysis | 2 | 2016 | 1136 | 0.120 |
Why?
| | Rural Population | 1 | 2016 | 472 | 0.120 |
Why?
| | Survival Rate | 1 | 2017 | 1851 | 0.120 |
Why?
| | Residence Characteristics | 1 | 2014 | 280 | 0.120 |
Why?
| | Multivariate Analysis | 2 | 2016 | 1599 | 0.120 |
Why?
| | Health Resources | 1 | 2013 | 129 | 0.120 |
Why?
| | Efficiency | 1 | 2012 | 97 | 0.120 |
Why?
| | beta Carotene | 1 | 2011 | 21 | 0.120 |
Why?
| | Interleukin-4 | 1 | 2012 | 231 | 0.110 |
Why?
| | Quality of Life | 2 | 2019 | 2089 | 0.110 |
Why?
| | Depression | 1 | 2020 | 1117 | 0.110 |
Why?
| | Patient Safety | 1 | 2014 | 311 | 0.110 |
Why?
| | Middle Aged | 4 | 2018 | 28676 | 0.110 |
Why?
| | Comparative Effectiveness Research | 1 | 2012 | 143 | 0.110 |
Why?
| | Critical Illness | 1 | 2016 | 576 | 0.110 |
Why?
| | Chi-Square Distribution | 1 | 2012 | 572 | 0.110 |
Why?
| | Treatment Outcome | 4 | 2019 | 8944 | 0.110 |
Why?
| | Academic Medical Centers | 1 | 2013 | 438 | 0.110 |
Why?
| | Health Services Accessibility | 3 | 2021 | 772 | 0.110 |
Why?
| | Saliva | 1 | 2012 | 222 | 0.110 |
Why?
| | Folic Acid | 1 | 2011 | 153 | 0.100 |
Why?
| | Comorbidity | 1 | 2015 | 1597 | 0.100 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2010 | 82 | 0.100 |
Why?
| | Vitamins | 1 | 2011 | 141 | 0.100 |
Why?
| | Practice Guidelines as Topic | 2 | 2015 | 1526 | 0.100 |
Why?
| | Insulin Resistance | 1 | 2018 | 1140 | 0.100 |
Why?
| | Antiviral Agents | 1 | 2016 | 635 | 0.100 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 2 | 2021 | 100 | 0.100 |
Why?
| | Health Surveys | 3 | 2006 | 497 | 0.100 |
Why?
| | Fellowships and Scholarships | 1 | 2012 | 207 | 0.100 |
Why?
| | Interleukin-1beta | 1 | 2012 | 415 | 0.100 |
Why?
| | Comprehension | 1 | 2011 | 158 | 0.100 |
Why?
| | New York | 3 | 2006 | 118 | 0.100 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2011 | 117 | 0.100 |
Why?
| | Communication | 1 | 2014 | 663 | 0.100 |
Why?
| | Inflammation | 1 | 2020 | 2427 | 0.100 |
Why?
| | Smokers | 2 | 2021 | 144 | 0.100 |
Why?
| | Health Literacy | 1 | 2011 | 135 | 0.100 |
Why?
| | Diabetes Mellitus | 1 | 2017 | 960 | 0.090 |
Why?
| | Anti-Bacterial Agents | 2 | 2015 | 1305 | 0.090 |
Why?
| | Interferon-gamma | 1 | 2012 | 804 | 0.090 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 1926 | 0.090 |
Why?
| | Killer Cells, Natural | 2 | 2021 | 386 | 0.090 |
Why?
| | Health Care Surveys | 1 | 2010 | 579 | 0.090 |
Why?
| | Logistic Models | 1 | 2013 | 2049 | 0.090 |
Why?
| | Acetaminophen | 1 | 2011 | 243 | 0.090 |
Why?
| | Anxiety | 1 | 2013 | 747 | 0.080 |
Why?
| | Betacoronavirus | 2 | 2020 | 264 | 0.080 |
Why?
| | Breast Neoplasms | 1 | 2018 | 1889 | 0.080 |
Why?
| | Preventive Medicine | 2 | 2005 | 40 | 0.080 |
Why?
| | Body Image | 1 | 2006 | 59 | 0.080 |
Why?
| | Caregivers | 1 | 2012 | 620 | 0.070 |
Why?
| | Magnetic Resonance Imaging | 1 | 2017 | 3017 | 0.070 |
Why?
| | Internship and Residency | 1 | 2014 | 947 | 0.070 |
Why?
| | Mass Screening | 1 | 2012 | 1038 | 0.070 |
Why?
| | Brain | 1 | 2017 | 2664 | 0.070 |
Why?
| | Plant Extracts | 1 | 2006 | 178 | 0.070 |
Why?
| | Diet | 1 | 2011 | 1070 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2370 | 0.060 |
Why?
| | Qualitative Research | 2 | 2021 | 754 | 0.060 |
Why?
| | Pregnancy, Unwanted | 1 | 2002 | 11 | 0.060 |
Why?
| | CD57 Antigens | 1 | 2021 | 19 | 0.060 |
Why?
| | CD56 Antigen | 1 | 2021 | 37 | 0.060 |
Why?
| | Homeless Youth | 1 | 2000 | 14 | 0.060 |
Why?
| | Chemokine CCL3 | 1 | 2020 | 16 | 0.050 |
Why?
| | Longitudinal Studies | 2 | 2020 | 2673 | 0.050 |
Why?
| | Causality | 1 | 2020 | 108 | 0.050 |
Why?
| | Intention | 1 | 2021 | 139 | 0.050 |
Why?
| | Interleukin-17 | 1 | 2020 | 117 | 0.050 |
Why?
| | Immunity, Humoral | 1 | 2020 | 93 | 0.050 |
Why?
| | Canada | 1 | 2020 | 330 | 0.050 |
Why?
| | Interleukin-18 | 1 | 2020 | 241 | 0.050 |
Why?
| | Down-Regulation | 1 | 2021 | 681 | 0.050 |
Why?
| | Perception | 1 | 2021 | 321 | 0.050 |
Why?
| | Shock, Septic | 1 | 2020 | 188 | 0.050 |
Why?
| | Substance-Related Disorders | 1 | 2006 | 946 | 0.040 |
Why?
| | Age Factors | 1 | 2006 | 3330 | 0.040 |
Why?
| | Peer Review | 1 | 2017 | 40 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2020 | 512 | 0.040 |
Why?
| | Congresses as Topic | 1 | 2017 | 209 | 0.040 |
Why?
| | Healthcare Disparities | 1 | 2021 | 462 | 0.040 |
Why?
| | Medically Underserved Area | 1 | 2016 | 103 | 0.040 |
Why?
| | Organizational Case Studies | 1 | 2014 | 73 | 0.040 |
Why?
| | Drug Utilization | 1 | 2016 | 182 | 0.040 |
Why?
| | Combined Modality Therapy | 1 | 2018 | 1240 | 0.040 |
Why?
| | Propensity Score | 1 | 2015 | 224 | 0.030 |
Why?
| | Neoplasm Staging | 1 | 2018 | 1220 | 0.030 |
Why?
| | Birth Weight | 1 | 2017 | 411 | 0.030 |
Why?
| | Antiemetics | 1 | 2014 | 34 | 0.030 |
Why?
| | Workflow | 1 | 2014 | 117 | 0.030 |
Why?
| | Social Facilitation | 1 | 2013 | 8 | 0.030 |
Why?
| | Infant, Premature | 1 | 2017 | 448 | 0.030 |
Why?
| | Postoperative Complications | 2 | 2015 | 2095 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2453 | 0.030 |
Why?
| | Patient Acceptance of Health Care | 1 | 2019 | 637 | 0.030 |
Why?
| | Autoantibodies | 1 | 2020 | 1208 | 0.030 |
Why?
| | Medicaid | 1 | 2016 | 358 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2016 | 577 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2020 | 1843 | 0.030 |
Why?
| | Medicare | 1 | 2016 | 590 | 0.030 |
Why?
| | Rabbits | 1 | 2013 | 816 | 0.030 |
Why?
| | Databases, Factual | 1 | 2016 | 1184 | 0.030 |
Why?
| | Drug Labeling | 1 | 2011 | 45 | 0.030 |
Why?
| | Chronic Disease | 1 | 2017 | 1666 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2018 | 4887 | 0.020 |
Why?
| | Emergency Service, Hospital | 1 | 2019 | 1721 | 0.020 |
Why?
| | Drug Therapy | 1 | 2005 | 83 | 0.020 |
Why?
| | Focus Groups | 1 | 2005 | 355 | 0.020 |
Why?
| | Life Style | 1 | 2006 | 437 | 0.020 |
Why?
| | Risk-Taking | 1 | 2006 | 364 | 0.020 |
Why?
| | Age Distribution | 1 | 2000 | 402 | 0.010 |
Why?
| | Sex Distribution | 1 | 2000 | 395 | 0.010 |
Why?
| | Emergency Medical Services | 1 | 2000 | 513 | 0.010 |
Why?
| | Animals | 1 | 2013 | 35194 | 0.010 |
Why?
|
|
Wilson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|